Abstract:Tau proteins are hyperphosphorylated at common sites in their N- and C-terminal domains in at least three neurodegenerative diseases, Parkinson, dementia with Lewy bodies, and Alzheimer's, suggesting specific pathology but general mechanism. Full-length human tau filament comprises a rigid core and a two-layered fuzzy coat. Tau is categorized into two groups of isoforms, with either four repeats (R1-R4) or three repeats (R1, R3, and R4); their truncated constructs are respectively called K18 and K19. Using multiscale molecular dynamics simulations, we explored the conformational consequences of hyperhposphorylation on tau's repeats. Our lower conformational energy filament models suggest a rigid filament core with a radius of ∼30 to 40 Å and an outer layer with a thickness of ∼140 Å consisting of a double-layered polyelectrolyte. The presence of the phosphorylated terminal domains alters the relative stabilities in the K18 ensemble, thus shifting the populations of the full-length filaments. However, the structure with the straight repeats in the core region is still the most stable, similar to the truncated K18 peptide species without the N- and C-terminus. Our simulations across different scales of resolution consistently reveal that hyperphosphorylation of the two terminal domains decreases the attractive interactions among the N- and C-terminus and repeat domain. To date, the relationship on the conformational level between phosphorylation and aggregation has not been understood. Our results suggest that the exposure of the repeat domain upon hyperphosphorylation could enhance tau filament aggregation. Thus, we discovered that even though these neurodegenerative diseases vary and their associated tau filaments are phosphorylated to different extents, remarkably, the three pathologies appear to share a common tau aggregation mechanism.

Molecular Insights into the Differential Effects of Acetylation on the Aggregation of Tau Microtubule-Binding Repeats

Deciphering the Effect of Lysine Acetylation on the Misfolding and Aggregation of Human Tau Fragment (171)IPAKTPPAPK(180) Using Molecular Dynamic Simulation and the Markov State Model

The Acetylation of Tau Inhibits Its Function and Promotes Pathological Tau Aggregation.

Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling.

Hyperacetylation mimetics within the tau filament core inhibits prion-like propagation of misfolded tau

Acetylation encodes Tau aggregation

A Unique Tau Conformation Generated by an Acetylation-Mimic Substitution Modulates P301S-dependent Tau Pathology and Hyperphosphorylation.

An acetylation–phosphorylation switch that regulates tau aggregation propensity and function

Structural Insight into Tau Protein'S Paradox of Intrinsically Disordered Behavior, Self-Acetylation Activity, and Aggregation

How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?

Uncovering the Effect of Ps202/pt205/ps208 Triple Phosphorylations on the Conformational Features of the Key Fragment G192-T212 of Tau Protein

Distinct Microscopic Mechanisms for the Accelerated Aggregation of Pathogenic Tau Mutants Revealed by Kinetic Analysis.

Atomistic Insights into the Inhibitory Mechanism of Tyrosine Phosphorylation Against the Aggregation of Human Tau Fragment PHF6.

O-GlcNAcylation Modulates the Self-Aggregation Ability of the Fourth Microtubule-Binding Repeat of Tau

The Self-Assembly Ability of the First Microtubule-Binding Repeat from Tau and Its Modulation by Phosphorylation

Phosphorylation of Tau R2 Repeat Destabilizes Its Binding to Microtubules: A Molecular Dynamics Simulation Study

Evaluating Triggers and Enhancers of Tau Fibrillization

Unravelling the Structure and Dynamics of Ac-PHF6-NH2 Tau Segment Oligomers

Unraveling the Structure and Dynamics of Ac-PHF6-NH2 Tau Segment Oligomers

Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis

Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss